trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Tai HH et al. Dynamic histone acetylation of late embryonic genes during seed germination. 2005 Plant Mol. Biol. pmid:16307366
Li XX et al. Function of c-Fos-like and c-Jun-like proteins on trichostatin A-induced G2/M arrest in Physarum polycephalum. 2005 Acta Biochim. Biophys. Sin. (Shanghai) pmid:16270156
Francia G et al. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents. 2005 Mol. Cancer Ther. pmid:16227397
Chou SD et al. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. 2005 Int. Immunol. pmid:16210330
Bai Y et al. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. 2005 J. Immunol. pmid:16210620
Chen G et al. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780]. 2005 Ai Zheng pmid:16219132
Di-Poï N et al. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. 2005 J. Biol. Chem. pmid:16166081
Spengler ML et al. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. 2005 Cell. Signal. pmid:15494207
Valenzuela-Fernández A et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. 2005 Mol. Biol. Cell pmid:16148047
Davis FJ et al. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15388503
Curtin BF et al. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. 2005 J. Cell. Biochem. pmid:16149071
Chen JS and Faller DV Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. 2005 J. Cell. Physiol. pmid:15389542
Medugno L et al. The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein. 2005 Gene pmid:16150558
Frønsdal K and Saatcioglu F Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. 2005 Prostate pmid:15389787
Li Y et al. Histone deacetylation is required for progression through mitosis in tobacco cells. 2005 Plant J. pmid:15659094
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Hooven LA et al. Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. 2005 Bioorg. Med. Chem. Lett. pmid:15713371
Chen B et al. Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:15713393
Duan H et al. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. 2005 Mol. Cell. Biol. pmid:15713621
Tong X et al. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. 2005 J. Biol. Chem. pmid:15713675
Kim MS et al. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). 2005 Exp. Cell Res. pmid:15878336
Rosenqvist N et al. Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain. 2005 Cell Transplant pmid:15881422
Gonçalves J et al. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. 2005 Clin. Chem. Lab. Med. pmid:15843208
Robbins AR et al. Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. 2005 Cell Cycle pmid:15846093
Taghiyev AF et al. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. 2005 Cancer Biol. Ther. pmid:15846101
Barki-Celli L et al. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. 2005 Genes Chromosomes Cancer pmid:15846776
Choi YH Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. 2005 Int. J. Oncol. pmid:16010430
Taddei A et al. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? 2005 EMBO Rep. pmid:15940285
Gray SG et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. 2005 J. Biol. Chem. pmid:15927959
Nishigaki M et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. 2005 Cancer Res. pmid:15781621
Bai J et al. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. 2005 Cancer Res. pmid:15781649
Rahmani M et al. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. 2005 Cancer Res. pmid:15781658
Frescas D et al. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. 2005 J. Biol. Chem. pmid:15788402
Kang J et al. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. 2005 Biochem. Pharmacol. pmid:15794941
Narayanan R et al. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. 2005 Mol. Cell. Biol. pmid:15798179
Cecconi D et al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. 2005 Nov-Dec J. Proteome Res. pmid:16335935
Garcia BA et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. 2005 Nov-Dec J. Proteome Res. pmid:16335948
Suzuki M et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. 2006 Oncogene pmid:16331260
Topark-Ngarm A et al. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. 2006 J. Biol. Chem. pmid:16950772
Akiyama T et al. Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16651529
Iacomino G et al. Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. 2006 J. Cell. Biochem. pmid:16795040
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Yu Z and Kone BC Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16174862
Kozłowska A and Jagodziński PP Effect of Trichostatin A on CD4 surface density in peripheral blood T cells. 2006 Folia Histochem. Cytobiol. pmid:17219719
He J et al. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219959
Wagner S et al. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. 2006 J. Biol. Chem. pmid:16861234
Zhang X et al. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. 2006 Oncol. Rep. pmid:16865256
Hellebrekers DM et al. Angiostatic activity of DNA methyltransferase inhibitors. 2006 Mol. Cancer Ther. pmid:16505122
Kong X et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. 2006 Mol. Cell. Biol. pmid:16507982
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182